SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039806
Filing Date
2020-08-13
Accepted
2020-08-13 08:02:34
Documents
55
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rapt-10q_20200630.htm 10-Q 2134409
2 EX-31.1 rapt-ex311_6.htm EX-31.1 16548
3 EX-31.2 rapt-ex312_7.htm EX-31.2 16515
4 EX-32.1 rapt-ex321_8.htm EX-32.1 14697
  Complete submission text file 0001564590-20-039806.txt   5517021

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT rapt-20200630.xml EX-101.INS 940058
6 XBRL TAXONOMY EXTENSION SCHEMA rapt-20200630.xsd EX-101.SCH 37154
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rapt-20200630_cal.xml EX-101.CAL 37251
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rapt-20200630_def.xml EX-101.DEF 115043
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE rapt-20200630_lab.xml EX-101.LAB 302838
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rapt-20200630_pre.xml EX-101.PRE 222805
Mailing Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 489-9000
RAPT Therapeutics, Inc. (Filer) CIK: 0001673772 (see all company filings)

IRS No.: 473313701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38997 | Film No.: 201097291
SIC: 2834 Pharmaceutical Preparations